12 West Capital Management’s RESPONSE GENETICS, INC COMMON SHS (DELAWARE) RGDX Stock Holding History

12 West Capital Management’s Portfolio RGDX Stock Details RGDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,447,617	Closed	-$798K	–	21
2015 Q2	$798K	Hold	2,447,617	–	–	0.09%	17
2015 Q1	$1.08M	Hold	2,447,617	–	–	0.12%	16
2014 Q4	$775K	Hold	2,447,617	–	–	0.1%	16
2014 Q3	$1.68M	Hold	2,447,617	–	–	0.2%	23
2014 Q2	$2.25M	Hold	2,447,617	–	–	0.29%	15
2014 Q1	$2.91M	Hold	2,447,617	–	–	0.47%	16
2013 Q4	$2.84M	Hold	2,447,617	–	–	0.45%	14
2013 Q3	$5.43M	Hold	2,447,617	–	–	0.78%	16
2013 Q2	$3.72M	Buy	+2,447,617	New	+$3.33M	0.59%	15

12 West Capital Management's RGDX Position: Q3 2015 in Review

12 West Capital Management sold out of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) in Q3 2015, closing a stake of 2,447,617 shares — an estimated $798K sold.

12 West Capital Management first reported a position in RGDX in Q2 2013 and held it in 9 quarters. The position peaked at $5.43M in Q3 2013. 1 fund tracked by Wall St. Rank holds RGDX as of Q3 2015.

12 West Capital Management reported no remaining RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position as of Q3 2015 after selling out during the quarter.
12 West Capital Management sold 2,447,617 RESPONSE GENETICS, INC COMMON SHS (DELAWARE) shares in Q3 2015, an estimated $798K.
12 West Capital Management first reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in Q2 2013 and held it in 9 quarters.
12 West Capital Management's RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position peaked at $5.43M in Q3 2013.
1 fund tracked by Wall St. Rank held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) as of Q3 2015.

Based on 12 West Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.